Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | AZN:LSE since announced | Transaction value |
---|---|---|
Fusion Pharmaceuticals Inc | 20.01% | 2.30bn |
Amolyt Pharma SAS | 18.08% | 1.05bn |
Gracell Biotechnologies Inc | 18.33% | 1.10bn |
Icosavax Inc | 22.31% | 862.87m |
Data delayed at least 20 minutes, as of Jun 03 2024 14:38 BST.
Holder | Shares | % Held |
---|---|---|
Caixa DTVM SAas of 31 Jan 2024 | 286.30k | 0.00% |
Data from 31 Jan 2024 - 31 Jan 2024Source: FactSet Research Systems Inc.